Skip to main content

Want a detailed portfolio tracker?

Aptevo Therapeutics (APVO) P/E (2024 - 2026)

Aptevo Therapeutics (APVO) P/E from Jul 1, 2024 to Jul 21, 2026. The TTM Aptevo Therapeutics (APVO) P/E is -0.08. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aptevo Therapeutics (APVO)

YearP/EChange
2026-0.08+8.58%
2025-0.07-97.25%
2024-2.65N/A

Comparison Aptevo Therapeutics (APVO) P/E with competitors

Aptevo Therapeutics (APVO) P/E is -0.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-102.15%
NBYStablecoin Development Corp0.00-105.43%
ENLVEnlivex Ltd0.07-194.44%
FGENFibroGen Inc0.24-403.07%
CHRSCoherus Biosciences Inc0.85-1171.34%
FBIOFortress Biotech Inc0.95-1298.23%
ORMPOramed Pharmaceuticals Inc1.50-1997.73%
AGENAgenus Inc3.01-3899.88%
INVAInnoviva Inc3.15-4082.20%
VXRTVaxart Inc3.55-4581.83%
CRMDCorMedix Inc3.63-4681.19%
CVACCureVac N.V.4.45-5713.01%
GLPGGalapagos NV4.86-6234.73%
SRPTSarepta Therapeutics Inc4.88-6264.02%
ABEOAbeona Therapeutics Inc5.39-6902.16%
ABUSArbutus Biopharma Corp5.60-7164.91%
ZVRAZevra Therapeutics Inc5.89-7533.09%
SPROSpero Therapeutics Inc6.23-7963.90%
CGENCompugen Ltd6.31-8071.86%
RIGLRigel Pharmaceuticals6.87-8776.53%
SLXNSilexion Therapeutics Corp7.30-9311.88%
OMEROmeros Corporation9.26-11789.92%
AUPHAurinia Pharmaceuticals Inc9.58-12201.79%
PLXProtalix BioTherapeutics Inc10.89-13850.78%
ACADAcadia Pharmaceuticals Inc11.73-14908.23%
TBPHTheravance Biopharma Inc12.26-15581.97%
ADMAAdma Biologics Inc12.42-15778.94%
HRMYHarmony Biosciences Holdings Inc13.82-17549.14%
SABSSAB Biotherapeutics Inc14.14-17948.13%
NAGENiagen Bioscience Inc14.82-18809.12%
INCYIncyte Corp15.82-20077.30%
REGNRegeneron Pharmaceuticals Inc15.86-20120.36%
PBYIPuma Biotechnology Inc17.32-21962.53%
CPRXCatalyst Pharmaceuticals Inc17.44-22118.59%
EXELExelixis Inc17.54-22243.22%
TGTXTG Therapeutics Inc18.97-24046.25%
MDXGMimedx Group Inc20.55-26049.28%
XOMAXOMA Royalty Corp22.87-28981.99%
ARGXArgen X SE24.30-30779.09%
CTMXCytomX Therapeutics Inc24.82-31439.57%
XOMAOXOMA Royalty Corp25.34-32100.81%
HALOHalozyme Therapeutics Inc25.62-32452.95%
XOMAPXOMA Royalty Corp25.67-32511.54%
VRTXVertex Pharmaceuticals Inc27.99-35446.65%
RPRXRoyalty Pharma plc - Class A28.69-36321.39%
SLNOSoleno Therapeutics Inc29.02-36735.28%
ASNDAscendis Pharma A/S30.09-38086.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-47968.38%
APLSApellis Pharmaceuticals Inc39.02-49368.89%
BMRNBiomarin Pharmaceutical Inc42.21-53397.43%
KRYSKrystal Biotech Inc45.34-57351.48%
ONCBeiGene Ltd69.54-87903.04%
PHARPharming Group N.V.75.03-94828.68%
TECHBio-Techne Corp101.96-128834.54%
VCELVericel Corp109.92-138888.72%
ALNYAlnylam Pharmaceuticals Inc117.96-149044.93%
GMABGenmab140.29-177233.73%
TLXTelix Pharmaceuticals Ltd162.15-204837.19%
CORTCorcept Therapeutics Inc212.86-268857.87%